Tocilizumab in Children With ACP
Condition:   Adamantinomatous Craniopharyngioma Intervention:   Drug: Tocilizumab Sponsors:   University of Colorado, Denver;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials

Neuromodulation for Hypothalamic Obesity
Conditions:   Craniopharyngioma;   Hypothalamic Obesity;   Metabolic Syndrome Intervention:   Device: Hypothalamic Deep Brain Stimulation Sponsor:   University of British Columbia Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2018 Category: Research Source Type: clinical trials